Cargando…

Energetics of Cardiac Blood Flow in Hypertrophic Cardiomyopathy through Individualized Computational Modeling

Hypertrophic cardiomyopathy (HCM) is a congenital heart disease characterized by thickening of the heart’s left ventricle (LV) wall that can lead to cardiac dysfunction and heart failure. Ventricular wall thickening affects the motion of cardiac walls and blood flow within the heart. Because abnorma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baenen, Owen, Carreño-Martínez, Angie Carolina, Abraham, Theodore P., Rugonyi, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607792/ https://www.ncbi.nlm.nih.gov/pubmed/37887858 http://dx.doi.org/10.3390/jcdd10100411

Ejemplares similares

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

Computational analysis of ventricular mechanics in hypertrophic cardiomyopathy patients
por: Mojumder, Joy, et al.
Publicado: (2023)

Mitochondrial Energetics and Ca(2+)-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy
por: Lombardi, Maria, et al.
Publicado: (2020)

Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016)

ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)
por: Güçlü, A., et al.
Publicado: (2013)

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
por: Toepfer, Christopher N., et al.
Publicado: (2020)

Native T1 is predictive of abnormal myocardial strain in hypertrophic cardiomyopathy
por: Jensen, Patrick J, et al.
Publicado: (2015)

Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy
por: Verschure, Derk O., et al.
Publicado: (2015)

Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy
por: Radbill, Andrew E., et al.
Publicado: (2021)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

In Hypertrophic Cardiomyopathy Reduction of Relative Resting Myocardial Blood Flow Is Related to Late Enhancement, T2-Signal and LV Wall Thickness
por: Hueper, Katja, et al.
Publicado: (2012)

Genetic and flow anomalies in congenital heart disease
por: Rugonyi, Sandra
Publicado: (2016)

Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy
por: Tolosana, José Maria, et al.
Publicado: (2018)

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy
por: Gi, Weng-Tein, et al.
Publicado: (2020)

Pheochromocytoma and Hypertrophic Cardiomyopathy Leading to Cardiac Arrest
por: Niu, Kevyn, et al.
Publicado: (2023)

Effect of Blood Flow on Cardiac Morphogenesis and Formation of Congenital Heart Defects
por: Trinidad, Fernando, et al.
Publicado: (2022)

Altered contractility in mutation-specific hypertrophic cardiomyopathy: A mechano-energetic in silico study with pharmacological insights
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2022)

Fetal Blood Flow and Genetic Mutations in Conotruncal Congenital Heart Disease
por: Dyer, Laura A., et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Left atrial strain assessment using cardiac computed tomography in patients with hypertrophic cardiomyopathy
por: Hosokawa, Takaaki, et al.
Publicado: (2023)

Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy
por: Lu, Dai‐Yin, et al.
Publicado: (2018)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
por: Ebrille, Elisa, et al.
Publicado: (2013)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
por: Despond, Evan A., et al.
Publicado: (2018)

Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―
por: Yoshihisa, Akiomi, et al.
Publicado: (2019)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Diastolic Paradoxic Jet Flow of the Right Ventricle in Hypertrophic Cardiomyopathy
por: Shirota, Ayumi, et al.
Publicado: (2020)

The predictive value of deep learning-based cardiac ultrasound flow imaging for hypertrophic cardiomyopathy complicating arrhythmias
por: Wu, Haotang, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy in Elderly Individuals: Is It a Rose by Another Name?
por: Lee, Deacon Z. J., et al.
Publicado: (2021)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Prevalence and prognostic implications of hypertensive response to exercise in patients with hypertrophic cardiomyopathy()
por: Lu, Dai-Yin, et al.
Publicado: (2023)

Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020)

Asymmetry of flow in aortic root and its application in hypertrophic obstructive cardiomyopathy
por: Francis, Nadine, et al.
Publicado: (2023)

Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_btln023b530s24fak6gclsmbk7